A potent mitochondria uncoupler
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

FCCP

Item No. 15218

Technical Information
Formal Name
2-[2-[4-(trifluoromethoxy)phenyl]hydrazinylidene]-propanedinitrile
CAS Number
370-86-5
Synonyms
  • Trifluoromethoxy carbonylcyanide phenylhydrazone
Molecular Formula
C10H5F3N4O
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMSO: 25 mg/ml
λmax
240, 356 nm
SMILES
N#C/C(C#N)=N/NC1=CC=C(OC(F)(F)F)C=C1
InChi Code
InChI=1S/C10H5F3N4O/c11-10(12,13)18-9-3-1-7(2-4-9)16-17-8(5-14)6-15/h1-4,16H
InChi Key
BMZRVOVNUMQTIN-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Product Description

    FCCP is a potent uncoupler of oxidative phosphorylation in mitochondria that disrupts ATP synthesis by transporting protons across cell membranes.1,2 At 40 μM, FCCP induces complete depolymerization of microtubules by increasing intracellular pH via the disruption of the mitochondrial H+ gradient and by decreasing the stability of microtubules by impairing the binding of microtubule-associated proteins.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Parker, V.H. Uncouplers of rat-liver mitochondrial oxidative phosphorylation. Biochem. J. 97(3), 658-662 (1965).

    2. Benz, R., and McLaughlin, S. The molecular mechanism of action of the proton ionophore FCCP (carbonylcyanide p-trifluoromethoxyphenylhydrazone). Biophys. J. 41(3), 381-398 (1983).

    3. Maro, B., Marty, M.C., and Bornens, M. In vivo and in vitro effects of the mitochondrial uncoupler FCCP on microtubules. EMBO J. 1(11), 1347-1352 (1982).

    Product Citations

    Bessho, R., Davidoff, O., Kobayashi, H., et alRegional metabolic analysis of structurally preserved kidney slices by ex vivo respirometry. Am. J. Physiol. Renal Physiol. 329(6), F796-F808 (2025).

    Nagakannan, P., Islam, M.I., Conrad, M., et alCathepsin B is an excutioner of ferroptosis. Biochim. Biophys. Acta Mol. Cell Res. 1868(3), 118928 (2021).

    Soriano-Castell, D., Currais, A., and Maher, P. Defining a pharmacological inhibitor fingerprint for oxytosis/ferroptosis. Free Radic. Biol. Med. S0891-5849(21), (2021).

    Izreig, S., Gariepy, A., Kaymak, I., et alRepression of LKB1 by miR-17~92 sensitizes MYC-dependent lymphoma to biguanide treatment. Cell Rep. Med. 1(2), 100014 (2020).

    Varalda, M., Antona, A., Bettio, V., et alPsychotropic drugs show anticancer activity by disrupting mitochondrial and lysosomal function. Front. Oncol. 10, 562196 (2020).

    Holmila, R.J., Vance, S.A., Chen, X., et alMitochondria-targeted probes for imaging protein sulfenylation. Sci. Rep. 8(1), 6635 (2018).